Page 56 - 2019_01-Haematologica-web

D. Ingenhag et al.
40. Sabo A, Kress TR, Pelizzola M, et al.
Selective transcriptional regulation by Myc in cellular growth control and lymphoma- genesis. Nature. 2014;511(7510):488-492.
41. Collado M, Gil J, Efeyan A, et al. Tumour biology: senescence in premalignant tumours. Nature. 2005;436(7051):642.
42. Braig M, Lee S, Loddenkemper C, et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature. 2005;436(7051):660-665.
43. Chen Z, Trotman LC, Shaffer D, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 2005; 436(7051): 725-730.
44. Akunuru S, Geiger H. Aging, Clonality, and
Rejuvenation of Hematopoietic Stem Cells.
Trends Mol Med. 2016;22(8):701-712.
45. Rossi DJ, Jamieson CH, Weissman IL. Stems cells and the pathways to aging and
cancer. Cell. 2008;132(4):681-696.
46. Rundberg Nilsson A, Soneji S, Adolfsson S, Bryder D, Pronk CJ. Human and Murine Hematopoietic Stem Cell Aging Is Associated with Functional Impairments and Intrinsic Megakaryocytic/Erythroid
t(7;12)(q36;p13) and t(7;12)(q32;p13)-- translocations involving ETV6 in children 18 months of age or younger with myeloid disorders. Leukemia. 2001;15(6):915-920.
49. Taketani T, Taki T, Sako M, Ishii T, Yamaguchi S, Hayashi Y. MNX1-ETV6 fusion gene in an acute megakaryoblastic leukemia and expression of the MNX1 gene in leukemia and normal B cell lines. Cancer Genet Cytogenet. 2008;186(2):115-
Bias. PloS One. 2016;11(7):e0158369. 119.
47. Satake N, Maseki N, Nishiyama M, et al. Chromosome abnormalities and MLL rearrangements in acute myeloid leukemia of infants. Leukemia. 1999;13(7):1013- 1017.
48. Slater RM, von Drunen E, Kroes WG, et al.
50. Balgobind BV, Hollink IH, Arentsen-Peters ST, et al. Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia. Haematologica. 2011; 96(10): 1478-1487.
46
haematologica | 2019; 104(1)